MetLife Investment Management’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-8,617
Closed -$1.83M 2882
2023
Q3
$1.83M Buy
8,617
+4
+0% +$799 0.01% 938
2023
Q2
$1.66M Buy
8,613
+374
+5% +$74.3K 0.01% 1009
2023
Q1
$1.67M Buy
8,239
+20
+0.2% +$3.21K 0.01% 980
2022
Q4
$1.06M Sell
8,219
-217
-3% -$28K 0.01% 1190
2022
Q3
$1.15M Buy
8,436
+6
+0.1% +$977 0.01% 1116
2022
Q2
$1.49M Buy
8,430
+339
+4% +$48.9K 0.01% 1018
2022
Q1
$1.17M Buy
+8,091
New +$1.09M 0.01% 1234
2019
Q2
Sell
-148
Closed -$10.8K 2619
2019
Q1
$10.8K Hold
148
﹤0.01% 2388
2018
Q4
$8.39K Buy
148
+1
+0.7% +$63 ﹤0.01% 2400
2018
Q3
$11.3K Buy
+147
New +$10.8K ﹤0.01% 2420

Other funds holding SGEN

MetLife Investment Management's SGEN Position: Q4 2023 in Review

MetLife Investment Management sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 8,617 shares — an estimated $1.83M sold.

MetLife Investment Management first reported a position in SGEN in Q3 2018 and held it in 10 quarters. The position peaked at $1.83M in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • MetLife Investment Management reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • MetLife Investment Management sold 8,617 Seagen Inc. Common Stock shares in Q4 2023, an estimated $1.83M.
  • MetLife Investment Management first reported a position in Seagen Inc. Common Stock in Q3 2018 and held it in 10 quarters.
  • MetLife Investment Management's Seagen Inc. Common Stock position peaked at $1.83M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on MetLife Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.